Twister Biotech Overview
- Founded
- 2011

- Status
- Private
- Employees
- 2

- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $1.12M

- Investors
- 1
Twister Biotech General Information
Description
Developer of gene therapies designed to treat rare cancers and autoimmune diseases. The company's gene therapies are a result of research, development, and commercialization of supercoiled DNA minicircles for transfer of DNA into primary and stem cells, enabling researchers to get better transfection efficiencies and longer-term effects and also that are easily delivered for safer, more effective gene and cell therapies.
Contact Information
- Post Office Box 20566
- Houston, TX 77225
- United States
Twister Biotech Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Later Stage VC | 11-Jan-2021 | $1.12M | 00.000 | Completed | Generating Revenue | |
1. Early Stage VC | Completed | Startup |
Twister Biotech Executive Team (4)
Twister Biotech Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
Lynn Zechiedrich Ph.D | Twister Biotech | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |
Mark Matovich | Twister Biotech | Board Member | 000 0000 |
Twister Biotech Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTwister Biotech Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
BCM Technologies | Venture Capital | Minority | 000 0000 | 000000 0 |